High Covid Risk Patients Least Likely To Get Monoclonal Antibodies: Study

According to new research, people over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs). -- a highly effective treatment for the...

from NDTV News - World-news https://ift.tt/VXcjuWv